Memo Therapeutics AG is a company that provides Monoclonal antibody, Biopharmaceutical, Immune repertoire and more. Memo Therapeutics AG is headquartered in Switzerland ZURICH. Memo Therapeutics AG was founded in 2012. Memo Therapeutics AG has a total of 40 patents
Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.
Its MemoMAB™ platform creates a recombinant...